Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Lynne, Sénécal"'
Autor:
Gan Zhen Liang, Marc Dorais, Suzon Collette, Lynne Sénécal, Majda Belkaid, Julie Turgeon, Héloïse Cardinal
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionAnimal models suggest a protective role of angiotensin-converting enzyme inhibitors (ACEi) and angiotensin-II receptor blockers (ARBs) in reducing renal and cardiac ischemia-reperfusion injury. Our aim was to determine the association bet
Externí odkaz:
https://doaj.org/article/f6ba535cc5d348a4a50a1669b3ec0917
Autor:
Habib Mawad, Louis Pinard, Samar Medani, Miguel Chagnon, Julie Boucquemont, Julie Turgeon, Mélanie Dieudé, Katia Hamelin, Annie Karakeussian Rimbaud, Ali Belayachi, Bing Yang, Suzon Collette, Lynne Sénécal, Bethany J. Foster, Marie-Josée Hébert, Héloïse Cardinal
Publikováno v:
Transplant International. 36
We previously reported associations between autoantibodies to the LG3 fragment of perlecan, anti-LG3, and a higher risk of delayed graft function (DGF) in kidney transplant recipients. Here, we aimed to determine whether some factors that modulate is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9a159e0fb10678c2fb2ca747f044ae9b
https://doi.org/10.3389/ti.2023.10749
https://doi.org/10.3389/ti.2023.10749
Autor:
Julie Leblanc, Peter Subrt, Michèle Paré, David Hartell, Lynne Sénécal, Tom Blydt-Hansen, Héloïse Cardinal
Publikováno v:
Canadian Journal of Kidney Health and Disease, Vol 5 (2018)
Background: One of the goals of the Canadian National Transplant Research Program (CNTRP) is to develop novel therapies for acute rejection that could positively affect graft outcomes with greater efficacy or less toxicity. To develop innovative mana
Externí odkaz:
https://doaj.org/article/3c351dc8b9254e4196a01051af7a2a32
Autor:
Rémi, Goupil, Alain, Bonnardeaux, Anne, Boucher, Suzon, Collette, Denis, Ouimet, Lynne, Sénécal, Duy, Tran, Michel, Vallée
Publikováno v:
Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation. 12(3)
Combined heart-kidney transplant has become an alternative for heart transplant candidates with significant chronic kidney disease. However, it is not clear which patients will benefit most from such intervention, and in whom cardiac transplant alone
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::43cdb0998f78959a53574f63085b6d77
https://pubmed.ncbi.nlm.nih.gov/24568727
https://pubmed.ncbi.nlm.nih.gov/24568727